Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm
Gynecologic Cancer
Related content
RECOMMENDED
Gynecologic Cancer
Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society
★ 3
Recommended by
Prof. Dr Beat Thürlimann, Faculty Member
CA Cancer J Clin.
Fontham ETH, Wolf AMD, Church TR, Etzioni R, Flowers CR, Herzig A, Guerra CE, Oeffinger KC, Shih YT, Walter LC, Kim JJ, Andrews KS, DeSantis CE, Fedewa SA, Manassaram-Baptiste D, Saslow D, Wender RC, Smith RA
doi: 10.3322/caac.21628.
Gynecologic CancerHead and Neck Cancer
The development of "Automated Visual Evaluation" for cervical cancer screening: The promise and challenges in adapting deep-learning for clinical testing
Int J Cancer
Desai KT, Befano B, Xue Z, Kelly H, Campos N, Egemen D, Gage J, Rodriguez AC, Sahasrabuddhe V, Levitz D, Pearlman P, Jeronimo J, Antani S, Schiffman M, de Sanjose S
doi: 10.1002/ijc.33879
Gynecologic Cancer
Methylation markers FAM19A4 and miR124-2 as triage strategy for primary HPV screen positive women; A large European multi-center study
Int J Cancer.
Bonde J, Floore A, Ejegod D, Vink FJ, Hesselink A, van de Ven PM, Oštrbenk Valenčak A, Pedersen H, Doorn S, Quint WG, Petry KU, Poljak M, Stanczuk G, Cuschieri K, de Sanjosé S, Bleeker M, Berkhof J, Meijer CJLM, Heideman DAM, Alcaniz E, Rothe B, Hortal MT, Del Pino M, Bhatia R
doi: 10.1002/ijc.33320.
Lung Cancer
Molecular Diagnostic and Precision Medicine in Non-Small Cell Lung Cancer. An Update on the Treatment of the Most Important Actionable Oncogenic Driver Alterations.
1Department of Medical Oncology, University Hospital Basel, Basel, Switzerland.
Gynecologic Cancer
Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial
Lancet Oncol.
Youn JW, Hur SY, Woo JW, Kim YM, Lim MC, Park SY, Seo SS, No JH, Kim BG, Lee JK, Shin SJ, Kim K, Chaney MF, Choi YJ, Suh YS, Park JS, Sung YC
doi: 10.1016/S1470-2045(20)30486-1.
Lung, Respiratory and Thoracic Cancer
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
Arch Pathol Lab Med.
Lindeman NI, Cagle PT, Aisner DL, Arcila ME, Beasley MB, Bernicker EH, Colasacco C, Dacic S, Hirsch FR, Kerr K, Kwiatkowski DJ, Ladanyi M, Nowak JA, Sholl L, Temple-Smolkin R, Solomon B, Souter LH, Thunnissen E, Tsao MS, Ventura CB, Wynes MW, Yatabe Y
doi: 10.5858/arpa.2017-0388-CP.
Gynecologic Cancer
Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review
Eur J Cancer.
Jansen EEL, Zielonke N, Gini A, Anttila A, Segnan N, Vokó Z, Ivanuš U, McKee M, de Koning HJ, de Kok IMCM, EU-TOPIA consortium
doi: 10.1016/j.ejca.2019.12.013.
Gynecologic Cancer
Performance of a DNA methylation marker panel using liquid-based cervical scrapes to detect cervical cancer and its precancerous stages
doi: 10.1186/s12885-018-5125-8.
Lung, Respiratory and Thoracic Cancer
Overdiagnosis in lung cancer screening - estimates from the German Lung Cancer Screening Intervention Trial
Int J Cancer.
González Maldonado S, Motsch E, Trotter A, Kauczor HU, Heussel CP, Hermann S, Zeissig SR, Delorme S, Kaaks R
doi: 10.1002/ijc.33295.